Analytical Data
-
Gene name
RAB11A
- Application
-
Alternative Names
YL8
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P62491
-
Expression Region
2-213aa
-
Molecular Weight
39.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RAB11A is a small GTPase belonging to the RAS superfamily and plays a critical role in intracellular membrane trafficking and recycling endosomes. Its involvement in various cellular processes, including the regulation of vesicular transport, signal transduction, and maintaining cellular homeostasis, makes it a significant focus of research in cell biology. Abnormalities in RAB11A function have been linked to several diseases, including cancer, neurodegenerative disorders, and autoimmune conditions, highlighting the importance of understanding its mechanisms of action. Researchers have been particularly interested in RAB11A recombinant protein due to its potential applications in drug development and therapeutic interventions. By studying the protein’s structure and function, scientists aim to elucidate its role in cellular pathways and identify novel targets for treatment. Additionally, recombinant RAB11A can be utilized in various assays to investigate its interactions with other proteins and its participation in cellular processes such as endocytosis, exocytosis, and cytokine release. Overall, the characterization of RAB11A recombinant protein not only enhances our understanding of fundamental cellular mechanisms but also paves the way for innovative strategies to address diseases linked to its dysfunction.
